N.A. Genomics
New Amsterdam Genomics (N.A.G.) is a precision medicine company leveraging AI, data, and statistics to optimize health and longevity through comprehensive DNA sequencing and analysis. Their platform integrates whole exome sequencing of all 22,000 genes with lab values and health data to create individualized care plans. N.A.G. uses advanced AI algorithms and natural language processing to analyze millions of scientific papers, providing actionable insights for disease risk, medication selection, diet, fitness, and lifestyle recommendations. Their technology is clinically validated, continuously updated, and used by over 700 doctors worldwide, delivering life-changing reports to 45% of clients, significantly more than typical DNA tests. The company operates on a doctor-ordered model, focusing on clinical utility and personalized medicine, positioning itself as a leader in AI-driven genomic healthcare.
N.A. Genomics
New Amsterdam Genomics (N.A.G.) is a precision medicine company leveraging AI, data, and statistics to optimize health and longevity through comprehensive DNA sequencing and analysis. Their platform integrates whole exome sequencing of all 22,000 genes with lab values and health data to create individualized care plans. N.A.G. uses advanced AI algorithms and natural language processing to analyze millions of scientific papers, providing actionable insights for disease risk, medication selection, diet, fitness, and lifestyle recommendations. Their technology is clinically validated, continuously updated, and used by over 700 doctors worldwide, delivering life-changing reports to 45% of clients, significantly more than typical DNA tests. The company operates on a doctor-ordered model, focusing on clinical utility and personalized medicine, positioning itself as a leader in AI-driven genomic healthcare.